Cidara Therap (CDTX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov25

Cidara Therapeutics Achieves Patient Enrollment Goal for ANCHOR Trial

10:06

Nov24

Merck & Co. Acquires Cidara Therapeutics for $9.2 Billion

03:52

Nov17

Merck Expects Over $5 Billion in Revenue from Cidara's Flu Drug

13:32

Merck Executives Indicate Cidara's Drug Can Go To Market Without CDC Approval

13:24

Nov15

Merck to Acquire Cidara Therapeutics for $9.2 Billion

10:58

Nov14

H.C. Wainwright analyst downgrades Cidara Therapeutics to hold

15:53

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -83.23 M, EPS -3.0961

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.72 M, EPS -1.6541

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -23.48 M, EPS -1.6561

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More